Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  HIV Infection

  Free Subscription


02.03.2020

4 AIDS
3 AIDS Res Hum Retroviruses
1 Am J Med
1 Antimicrob Agents Chemother
1 Arch Dis Child
1 BMJ
1 Br J Haematol
8 Clin Infect Dis
16 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Med Virol
1 J Virol
3 Lancet
1 Lancet Glob Health
8 Lancet HIV
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
2 Pediatr Infect Dis J
1 PLoS Comput Biol
3 PLoS Med
13 PLoS One
4 PLoS Pathog
1 Proc Natl Acad Sci U S A
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. BOZZI G, Squillace N, Peri AM, Muscatello A, et al
    Immunological failure in an HIV elite controller: possible role of indirect markers of inflammation and benefit of antiretroviral therapy.
    AIDS. 2020;34:646-647.
    PubMed     Text format    

  2. GREEN JA, Lum T
    Reply to the letter to the editor: antibody-mediated control of HIV-1 through an alternative pathway.
    AIDS. 2020;34:645.
    PubMed     Text format    

  3. XIA Q, Lim S, Wu B, Forgione LA, et al
    Estimating the probability of diagnosis within one year of HIV acquisition.
    AIDS. 2020 Feb 20. doi: 10.1097/QAD.0000000000002510.
    PubMed     Text format     Abstract available

  4. ANGELOVICH TA, Trevillyan JM, Hoy JF, Wong ME, et al
    Monocytes from men living with HIV exhibit heightened atherogenic potential despite long-term viral suppression with antiretroviral therapy.
    AIDS. 2020;34:513-518.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  5. YAO T, Wu J, Zhang Y, Shen Y, et al
    Near Full-Length Genomic Characterization of A Novel Unique Recombinant (CRF01_AE/07_BC) In Fuyang city of China.
    AIDS Res Hum Retroviruses. 2020 Feb 20. doi: 10.1089/AID.2020.0002.
    PubMed     Text format     Abstract available

  6. APORNPONG T, Han WM, Chattranukulchai P, Siwamogsatham S, et al
    Higher proportion of abnormal nutritional status among well suppressed HIV-infected elderly Asians compared to HIV-negative individuals.
    AIDS Res Hum Retroviruses. 2020 Feb 24. doi: 10.1089/AID.2019.0285.
    PubMed     Text format     Abstract available

  7. NESAKUMAR M, Haribabu H, Kk VV, Precilla LK, et al
    Genetic Characterization of full length HIV-2 Long Terminal Repeat (LTR) sequences: Identification of rare promoter variants.
    AIDS Res Hum Retroviruses. 2020 Feb 27. doi: 10.1089/AID.2020.0027.
    PubMed     Text format     Abstract available


    Am J Med

  8. MEYER MJ, Carlson JJ, Lin D
    Seeing Snakes: An HIV Patient with Visual Hallucinations.
    Am J Med. 2020 Feb 17. pii: S0002-9343(19)30955.
    PubMed     Text format    


    Antimicrob Agents Chemother

  9. PENG W, Hong Z, Chen X, Gao H, et al
    Thiostrepton reactivates latent HIV-1 through p-TEFb and NF-kappaB pathway mediated by heat shock response.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02328.
    PubMed     Text format     Abstract available


    Arch Dis Child

  10. WILLIAMS B, Boullier M, Cricks Z, Ward A, et al
    Screening for infection in unaccompanied asylum-seeking children and young people.
    Arch Dis Child. 2020 Feb 24. pii: archdischild-2019-318077.
    PubMed     Text format     Abstract available


    BMJ

  11. GOGA A, Singh Y, Jackson D, Pillay Y, et al
    Authors' reply to Shaffer and colleagues.
    BMJ. 2020;368:m564.
    PubMed     Text format    


    Br J Haematol

  12. ABRAHAO R, Li QW, Malogolowkin MH, Alvarez EM, et al
    Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.
    Br J Haematol. 2020 Feb 20. doi: 10.1111/bjh.16539.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  13. DEBROY P, Lake JE, Moser C, Olefsky M, et al
    Antiretroviral therapy initiation is associated with decreased visceral and subcutaneous adipose tissue density in people living with HIV.
    Clin Infect Dis. 2020 Feb 28. pii: 5763206. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. SMITH DK, Sullivan PS, Cadwell B, Waller LA, et al
    Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.
    Clin Infect Dis. 2020 Feb 25. pii: 5758031. doi: 10.1093/cid/ciz1229.
    PubMed     Text format     Abstract available

  15. MARCUS JL, Paltiel AD, Walensky RP
    Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out.
    Clin Infect Dis. 2020 Feb 25. pii: 5758030. doi: 10.1093/cid/ciz1236.
    PubMed     Text format    

  16. LAKE JE, Wu K, Bares SH, Debroy P, et al
    Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.
    Clin Infect Dis. 2020 Feb 26. pii: 5758067. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. BOLLEN P, Freriksen J, Konopnicki D, Weizsacker K, et al
    The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2020 Feb 26. pii: 5760700. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. KELLY C, Tinago W, Alber D, Hunter P, et al
    Inflammatory Phenotypes Predict Changes in Arterial Stiffness following ART Initiation.
    Clin Infect Dis. 2020 Feb 27. pii: 5760863. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. LAMA JR, Ignacio RAB, Alfaro R, Rios J, et al
    Clinical and Immunologic Outcomes after Immediate or Deferred Antiretroviral Therapy Initiation during Primary HIV Infection: The Sabes Randomized Clinical Study.
    Clin Infect Dis. 2020 Feb 28. pii: 5763087. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. PINTYE J, Kinuthia J, Abuna F, Mugwanya K, et al
    Frequency and predictors of tenofovir-diphosphate detection among young Kenyan women in a real-world pre-exposure prophylaxis implementation program.
    Clin Infect Dis. 2020 Feb 28. pii: 5766394. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  21. TAYLOR K, Lamb M, Lahuerta M, Ahoua L, et al
    Patterns and Predictors of HIV Status Disclosure in the 12 Months Following Diagnosis in Mozambique.
    J Acquir Immune Defic Syndr. 2020 Feb 20. doi: 10.1097/QAI.0000000000002334.
    PubMed     Text format     Abstract available


  22. Characteristics and Care Outcomes Among Persons Living With Perinatally Acquired HIV Infection in the United States, 2015: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e28.
    PubMed     Text format    


  23. Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e28.
    PubMed     Text format    

  24. CASTILHO JL, Rebeiro PF, Shepherd BE, Nash R, et al
    Mood Disorders and Increased Risk of Noncommunicable Disease in Adults With HIV.
    J Acquir Immune Defic Syndr. 2020;83:397-404.
    PubMed     Text format     Abstract available

  25. VAUGHAN J, Perner Y, McAlpine E, Wiggill T, et al
    Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020;83:345-349.
    PubMed     Text format     Abstract available

  26. CROCKETT KB, Entler KJ, Brodie E, Kempf MC, et al
    Brief Report: Linking Depressive Symptoms to Viral Nonsuppression Among Women With HIV Through Adherence Self-Efficacy and ART Adherence.
    J Acquir Immune Defic Syndr. 2020;83:340-344.
    PubMed     Text format     Abstract available

  27. JUMARE J, Akolo C, Ndembi N, Bwala S, et al
    Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naive Individuals in Nigeria.
    J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002320.
    PubMed     Text format     Abstract available

  28. STABELL AC, Wilson M, Jankowski CM, MaWhinney S, et al
    The Impact of a Structured, Supervised Exercise Program on Daily Step Count in Sedentary Older Adults With and Without HIV.
    J Acquir Immune Defic Syndr. 2020 Feb 20. doi: 10.1097/QAI.0000000000002326.
    PubMed     Text format     Abstract available

  29. SHUTER J, Kim RS, Durant S, Stanton CA, et al
    Long-term follow-up of smokers living with HIV after an intensive behavioral tobacco treatment intervention.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002330.
    PubMed     Text format     Abstract available

  30. PUTTKAMMER N, Parrish C, Desir Y, Hyppolite N, et al
    Toward Universal HIV Treatment in Haiti: Time Trends in ART Retention Following Expanded ART Eligibility in a National Cohort from 2011-17.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002329.
    PubMed     Text format     Abstract available

  31. HERSBERGER M, Schlaepfer E, Buehler M, Bochud PY, et al
    Polymorphisms of SOCS-1 are associated with rapid HIV progression rate.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002319.
    PubMed     Text format     Abstract available

  32. GILLIS JL, Grennan T, Grewal R, Ogilvie G, et al
    Racial disparities in anal cancer screening among men living with HIV: findings from a clinical cohort study.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002335.
    PubMed     Text format     Abstract available

  33. FATTI G, Ngorima-Mabhena N, Mothibi E, Muzenda T, et al
    Outcomes of Three versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002333.
    PubMed     Text format     Abstract available

  34. CRAW JA, Beer L, Tie Y, Jaenicke T, et al
    Viral rebound among persons with diagnosed HIV who achieved viral suppression, United States.
    J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002321.
    PubMed     Text format     Abstract available

  35. CHIKANDIWA A, Faust H, Chersich MF, Mayaud P, et al
    Human papillomavirus seroprevalence and seroconversion among men living with HIV: Cohort study in South Africa.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002328.
    PubMed     Text format     Abstract available

  36. GORI A, Antinori A, Vergori A, Cossu MV, et al
    Effectiveness of switching to darunavir/cobicistat in virologically-suppressed HIV-positive patients receiving ritonavir-boosted protease inhibitor-based regimen: the "STORE" Study.
    J Acquir Immune Defic Syndr. 2020 Feb 24. doi: 10.1097/QAI.0000000000002331.
    PubMed     Text format     Abstract available


    J Clin Invest

  37. MALDARELLI F
    The gift of a lifetime: analysis of HIV at autopsy.
    J Clin Invest. 2020 Feb 24. pii: 135905. doi: 10.1172/JCI135905.
    PubMed     Text format     Abstract available


    J Med Virol

  38. LI X, Zai J, Zhao Q, Nie Q, et al
    Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25731.
    PubMed     Text format     Abstract available


    J Virol

  39. JOHNSON J, Flores MG, Rosa J, Han C, et al
    The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals that Target High-mannose Glycans.
    J Virol. 2020 Feb 26. pii: JVI.01749-19. doi: 10.1128/JVI.01749.
    PubMed     Text format     Abstract available


    Lancet

  40. LEWIN SR, Rasmussen TA
    Kick and kill for HIV latency.
    Lancet. 2020 Feb 18. pii: S0140-6736(20)30264.
    PubMed     Text format    

  41. FIDLER S, Stohr W, Pace M, Dorrell L, et al
    Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
    Lancet. 2020 Feb 18. pii: S0140-6736(19)32990.
    PubMed     Text format     Abstract available

  42. CLARK H, Coll-Seck AM, Banerjee A, Peterson S, et al
    A future for the world's children? A WHO-UNICEF-Lancet Commission.
    Lancet. 2020;395:605-658.
    PubMed     Text format    


    Lancet Glob Health

  43. LIM AG, Walker JG, Mafirakureva N, Khalid GG, et al
    Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis.
    Lancet Glob Health. 2020;8:e440-e450.
    PubMed     Text format     Abstract available


    Lancet HIV

  44. CELUM C, Baeten JM
    Lessons on PrEP from the SEARCH study in east Africa.
    Lancet HIV. 2020 Feb 19. pii: S2352-3018(20)30003.
    PubMed     Text format    

  45. JIN F, Poynten IM, Grulich AE
    HIV treatment and anal cancer: emerging clarity.
    Lancet HIV. 2020 Feb 25. pii: S2352-3018(20)30027.
    PubMed     Text format    

  46. KOSS CA, Charlebois ED, Ayieko J, Kwarisiima D, et al
    Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Lancet HIV. 2020 Feb 19. pii: S2352-3018(19)30433.
    PubMed     Text format     Abstract available

  47. HELLARD M, Ryan KE, Stoove M
    Point-of-care HIV testing can help achieve UNAIDS targets.
    Lancet HIV. 2020 Feb 24. pii: S2352-3018(20)30043.
    PubMed     Text format    

  48. DRAIN PK, Dorward J, Violette LR, Quame-Amaglo J, et al
    Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.
    Lancet HIV. 2020 Feb 24. pii: S2352-3018(19)30402.
    PubMed     Text format     Abstract available

  49. LAMORDE M, Atwiine M, Owarwo NC, Ddungu A, et al
    Dolutegravir-associated hyperglycaemia in patients with HIV.
    Lancet HIV. 2020 Feb 24. pii: S2352-3018(20)30042.
    PubMed     Text format    


  50. Correction to Lancet HIV 2020; 7: e84.
    Lancet HIV. 2020 Feb 24. pii: S2352-3018(20)30052.
    PubMed     Text format    

  51. KELLY H, Chikandiwa A, Alemany Vilches L, Palefsky JM, et al
    Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.
    Lancet HIV. 2020 Feb 25. pii: S2352-3018(19)30434.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  52. WILLIAMS CM, Abdulwhhab M, Birring SS, De Kock E, et al
    Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(19)30707.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  53. DJOMAND G, Bingham T, Benech I, Muthui M, et al
    Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016-September 2018.
    MMWR Morb Mortal Wkly Rep. 2020;69:212-215.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  54. NDUBA V, Kaguthi G, Van't Hoog AH, Mitchell EMH, et al
    The Incidence of Tuberculosis in Infants, Siaya District, Western Kenya.
    Pediatr Infect Dis J. 2020 Feb 20. doi: 10.1097/INF.0000000000002616.
    PubMed     Text format     Abstract available

  55. FERNANDEZ-LUIS S, Nhampossa T, Fuente-Soro L, Augusto O, et al
    Pediatric HIV Care Cascade in Southern Mozambique: Missed Opportunities for Early ART and Re-engagement in Care.
    Pediatr Infect Dis J. 2020 Feb 20. doi: 10.1097/INF.0000000000002612.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  56. REEVES DB, Huang Y, Duke ER, Mayer BT, et al
    Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.
    PLoS Comput Biol. 2020;16:e1007626.
    PubMed     Text format     Abstract available


    PLoS Med

  57. LAHER F, Moodie Z, Cohen KW, Grunenberg N, et al
    Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    PLoS Med. 2020;17:e1003038.
    PubMed     Text format     Abstract available

  58. LIENHARDT C, Nunn A, Chaisson R, Vernon AA, et al
    Advances in clinical trial design: Weaving tomorrow's TB treatments.
    PLoS Med. 2020;17:e1003059.
    PubMed     Text format     Abstract available

  59. HERMANS LE, Carmona S, Nijhuis M, Tempelman HA, et al
    Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
    PLoS Med. 2020;17:e1003037.
    PubMed     Text format     Abstract available


    PLoS One

  60. TOLA HH, Holakouie-Naieni K, Mansournia MA, Yaseri M, et al
    Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study.
    PLoS One. 2020;15:e0229284.
    PubMed     Text format     Abstract available

  61. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
    PLoS One. 2020;15:e0229577.
    PubMed     Text format     Abstract available

  62. HUIBERS MHW, Bates I, McKew S, Allain TJ, et al
    Severe anaemia complicating HIV in Malawi; Multiple co-existing aetiologies are associated with high mortality.
    PLoS One. 2020;15:e0218695.
    PubMed     Text format     Abstract available

  63. MUNUSAMY PONNAN S, Hayes P, Fernandez N, Thiruvengadam K, et al
    Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India.
    PLoS One. 2020;15:e0229461.
    PubMed     Text format     Abstract available

  64. SMITH SL, Franke MF, Rusangwa C, Mukasakindi H, et al
    Outcomes of a primary care mental health implementation program in rural Rwanda: A quasi-experimental implementation-effectiveness study.
    PLoS One. 2020;15:e0228854.
    PubMed     Text format     Abstract available

  65. HARB AK, Mohammed H, Furegato M, Wayal S, et al
    The association between region of birth and sexually transmitted infections among people of black Caribbean ethnicity attending sexual health services in England, 2015.
    PLoS One. 2020;15:e0228654.
    PubMed     Text format     Abstract available

  66. TZOU PL, Kosakovsky Pond SL, Avila-Rios S, Holmes SP, et al
    Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.
    PLoS One. 2020;15:e0225352.
    PubMed     Text format     Abstract available

  67. ADENIYI OV, Ajayi AI
    Level and determinants of postpartum adherence to antiretroviral therapy in the Eastern Cape, South Africa.
    PLoS One. 2020;15:e0229592.
    PubMed     Text format     Abstract available

  68. VISWASAM N, Lyons CE, MacAllister J, Millett G, et al
    The uptake of population size estimation studies for key populations in guiding HIV responses on the African continent.
    PLoS One. 2020;15:e0228634.
    PubMed     Text format     Abstract available

  69. JAGODZINSKI LL, Manak MM, Hack HR, Liu Y, et al
    Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA.
    PLoS One. 2020;15:e0229424.
    PubMed     Text format     Abstract available

  70. MCMAHON C, Trevaskis JL, Carter C, Holsapple K, et al
    Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight.
    PLoS One. 2020;15:e0229617.
    PubMed     Text format     Abstract available

  71. AMENDOLA A, Sberna G, Forbici F, Abbate I, et al
    Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
    PLoS One. 2020;15:e0230018.
    PubMed     Text format     Abstract available

  72. HUIBERS MHW, Calis JC, Allain TJ, Coupland SE, et al
    A possible role for hepcidin in the detection of iron deficiency in severely anaemic HIV-infected patients in Malawi.
    PLoS One. 2020;15:e0218694.
    PubMed     Text format     Abstract available


    PLoS Pathog

  73. VAN DER SLUIS RM, Zerbato JM, Rhodes JW, Pascoe RD, et al
    Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
    PLoS Pathog. 2020;16:e1008151.
    PubMed     Text format     Abstract available

  74. SEOANE PI, Taylor-Smith LM, Stirling D, Bell LCK, et al
    Viral infection triggers interferon-induced expulsion of live Cryptococcus neoformans by macrophages.
    PLoS Pathog. 2020;16:e1008240.
    PubMed     Text format     Abstract available

  75. CHU TH, Crowley AR, Backes I, Chang C, et al
    Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.
    PLoS Pathog. 2020;16:e1008083.
    PubMed     Text format     Abstract available

  76. COOMER CA, Carlon-Andres I, Iliopoulou M, Dustin ML, et al
    Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion.
    PLoS Pathog. 2020;16:e1008359.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  77. BURDICK RC, Li C, Munshi M, Rawson JMO, et al
    HIV-1 uncoats in the nucleus near sites of integration.
    Proc Natl Acad Sci U S A. 2020 Feb 24. pii: 1920631117.
    PubMed     Text format     Abstract available


    Vaccine

  78. ZHOU Y, Lin YF, Meng X, Duan Q, et al
    Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30176.
    PubMed     Text format     Abstract available

  79. CHURCH JA, Chasekwa B, Rukobo S, Govha M, et al
    Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30150.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: